Results
|
|
1961.
|
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study. [electronic resource] by
- Cortazar, Frank B
- Kibbelaar, Zoe A
- Glezerman, Ilya G
- Abudayyeh, Ala
- Mamlouk, Omar
- Motwani, Shveta S
- Murakami, Naoka
- Herrmann, Sandra M
- Manohar, Sandhya
- Shirali, Anushree C
- Kitchlu, Abhijat
- Shirazian, Shayan
- Assal, Amer
- Vijayan, Anitha
- Renaghan, Amanda DeMauro
- Ortiz-Melo, David I
- Rangarajan, Sunil
- Malik, A Bilal
- Hogan, Jonathan J
- Dinh, Alex R
- Shin, Daniel Sanghoon
- Marrone, Kristen A
- Mithani, Zain
- Johnson, Douglas B
- Hosseini, Afrooz
- Uprety, Deekchha
- Sharma, Shreyak
- Gupta, Shruti
- Reynolds, Kerry L
- Sise, Meghan E
- Leaf, David E
Producer: 20200904
In:
Journal of the American Society of Nephrology : JASN vol. 31
Availability: No items available.
|
|
|
1962.
|
|
|
|
1963.
|
|
|
|
1964.
|
Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer. [electronic resource] by
- Reisenbichler, Emily S
- Han, Gang
- Bellizzi, Andrew
- Bossuyt, Veerle
- Brock, Jane
- Cole, Kimberly
- Fadare, Oluwole
- Hameed, Omar
- Hanley, Krisztina
- Harrison, Beth T
- Kuba, M Gabriela
- Ly, Amy
- Miller, Dylan
- Podoll, Mirna
- Roden, Anja C
- Singh, Kamaljeet
- Sanders, Mary Ann
- Wei, Shi
- Wen, Hannah
- Pelekanou, Vasiliki
- Yaghoobi, Vesal
- Ahmed, Fahad
- Pusztai, Lajos
- Rimm, David L
Producer: 20210720
In:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 33
Availability: No items available.
|
|
|
1965.
|
PD-L1 expression level in different thymoma stages and thymic carcinoma: a meta-analysis. [electronic resource] by
- Chen, Hua-Fei
- Wu, Li-Xin
- Li, Xiao-Feng
- Zhu, You-Cai
- Pan, Wei-Wei
- Wang, Wen-Xian
- Xu, Chun-Wei
- Huang, Jian-Hui
- Wu, Min-Hua
- Du, Kai-Qi
Producer: 20200803
In:
Tumori vol. 106
Availability: No items available.
|
|
|
1966.
|
|
|
|
1967.
|
|
|
|
1968.
|
|
|
|
1969.
|
|
|
|
1970.
|
|
|
|
1971.
|
MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs. [electronic resource] by
- Pyzer, A R
- Stroopinsky, D
- Rosenblatt, J
- Anastasiadou, E
- Rajabi, H
- Washington, A
- Tagde, A
- Chu, J-H
- Coll, M
- Jiao, A L
- Tsai, L T
- Tenen, D E
- Cole, L
- Palmer, K
- Ephraim, A
- Leaf, R K
- Nahas, M
- Apel, A
- Bar-Natan, M
- Jain, S
- McMasters, M
- Mendez, L
- Arnason, J
- Raby, B A
- Slack, F
- Kufe, D
- Avigan, D
Producer: 20171215
In:
Leukemia vol. 31
Availability: No items available.
|
|
|
1972.
|
|
|
|
1973.
|
|
|
|
1974.
|
|
|
|
1975.
|
|
|
|
1976.
|
|
|
|
1977.
|
Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status. [electronic resource] by
- Baverel, Paul G
- Dubois, Vincent F S
- Jin, Chao Yu
- Zheng, Yanan
- Song, Xuyang
- Jin, Xiaoping
- Mukhopadhyay, Pralay
- Gupta, Ashok
- Dennis, Phillip A
- Ben, Yong
- Vicini, Paolo
- Roskos, Lorin
- Narwal, Rajesh
Producer: 20190514
In:
Clinical pharmacology and therapeutics vol. 103
Availability: No items available.
|
|
|
1978.
|
|
|
|
1979.
|
|
|
|
1980.
|
|